Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06082414
Other study ID # 2019(21)
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 30, 2019
Est. completion date January 29, 2020

Study information

Verified date October 2023
Source Peking University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

to estimate incidences of major complications, such as bronchopulmonary dysplasia, death, and delivery room resuscitation among extremely preterm and extremely low birth weight infants in Northern China


Description:

to estimate incidences and risk factors of bronchopulmonary dysplasia, death, and delivery room resuscitation among extremely preterm and extremely low birth weight infants in Northern China


Recruitment information / eligibility

Status Completed
Enrollment 1200
Est. completion date January 29, 2020
Est. primary completion date January 29, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 72 Hours
Eligibility Inclusion Criteria: 1. born between January 1, 2015, and December 31, 2018; 2. a birth weight <1000grams or a gestational age <28 weeks; 3. admitted within 72 hours after birth. Exclusion Criteria: No medical history in the electronic record

Study Design


Related Conditions & MeSH terms


Intervention

Other:
no interventions
no interventions because of an observational study

Locations

Country Name City State
China Qi Feng Beijing Beijing

Sponsors (19)

Lead Sponsor Collaborator
Peking University Beijing Children's Hospital, Beijing Friendship Hospital, Chifeng Municipal Hospital, Children's Hospital of Hebei Province, Handan Central Hospital, Peking Union Medical College Hospital, Peking University First Hospital, Peking University People's Hospital, Peking University Third Hospital, PLA Rocket Force Characteristic Medical Center, Shanxi Provincial Maternity and Children's Hospital, The Affiliated Hospital of Inner Mongolia Medical University, The Second Hospital of Hebei Medical University, Tianjin Central Hospital of Gynecology Obstetrics, Tianjin First Central Hospital, Tianjin Medical University General Hospital, Tianjin Medical University Second Hospital, Xingtai People's Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary incidences to investigate incidences of bronchopulmonary dysplasia at 36 weeks' corrected age (CA) or at discharge
Primary risk factors to investigate risk factors of bronchopulmonary dysplasia at 36 weeks' corrected age (CA) or at discharge
Primary incidences of delivery room resuscitation to investigate incidences of delivery room resuscitation on admission
Primary risk factors of delivery room resuscitation to investigate risk factors of delivery room resuscitation on admission
See also
  Status Clinical Trial Phase
Terminated NCT04506619 - Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants
Completed NCT04936477 - Ventilation-perfusion (V/Q) Ratio and Alveolar Surface Area in Preterm Infants N/A
Recruiting NCT05285345 - Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease
Completed NCT03649932 - Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing Phase 1
Terminated NCT02524249 - Early Versus Late Caffeine for ELBW Newborns N/A
Completed NCT02249143 - Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants N/A
Active, not recruiting NCT01632475 - Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia
Completed NCT01460576 - Improving Prematurity-Related Respiratory Outcomes at Vanderbilt N/A
Completed NCT00419588 - Growth of Airways and Lung Tissues in Premature and Healthy Infants
Unknown status NCT00254176 - Cysteine Supplementation in Critically Ill Neonates Phase 2/Phase 3
Completed NCT00319956 - Trial II of Lung Protection With Azithromycin in the Preterm Infant Phase 2
Completed NCT00208039 - Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates N/A
Completed NCT00006401 - Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants Phase 3
Terminated NCT05030012 - Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants N/A
Completed NCT00006058 - Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns N/A
Completed NCT00005376 - Premature Birth and Its Sequelae in Women N/A
Completed NCT00011362 - Dexamethasone Therapy in VLBW Infants at Risk of CLD Phase 3
Completed NCT00004805 - Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden Death N/A
Completed NCT05152316 - The Baby Lung Study
Recruiting NCT04821453 - NAVA vs. CMV Crossover in Severe BPD N/A